A striking example is Abbott, whose dividend has been growing annually for 54 years. Abbott's P/E (Price/Earnings) estimate for Q3 2023 is 36.74, indicating that the shares are highly profitable.
Dexcom's CEO Kevin Sayer celebrates a successful year of 2023 with a record number of new customers and impressive global growth.
MLC is on the right track to grow in the promising MedTech technology niche with steady progress towards achieving its market goals!
